| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 2.425 | 8.903 | 17.235 | 25.617 | 31.507 | 34.711 | 41.598 | 35.701 |
| Total Income - EUR | - | - | 2.425 | 8.903 | 17.235 | 25.617 | 31.507 | 36.673 | 41.598 | 35.701 |
| Total Expenses - EUR | - | - | 1.095 | 3.370 | 11.752 | 11.602 | 21.779 | 20.568 | 19.401 | 33.221 |
| Gross Profit/Loss - EUR | - | - | 1.330 | 5.533 | 5.484 | 14.015 | 9.728 | 16.106 | 22.197 | 2.481 |
| Net Profit/Loss - EUR | - | - | 1.258 | 5.272 | 4.966 | 13.608 | 9.450 | 15.765 | 21.789 | 1.570 |
| Employees | - | - | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Novorehab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 870 | 11.987 | 11.387 | 20.312 | 16.988 | 13.556 | 10.388 |
| Current Assets | - | - | 2.111 | 7.552 | 10.620 | 20.467 | 21.115 | 16.847 | 10.750 | 10.084 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 182 | 5.813 | 1.486 | 178 | 723 | 10.306 | 1.064 | 767 |
| Cash | - | - | 1.929 | 1.739 | 9.135 | 20.289 | 20.393 | 6.541 | 9.686 | 9.316 |
| Shareholders Funds | - | - | 1.301 | 6.550 | 11.390 | 24.782 | 33.682 | 15.814 | 21.838 | 18.915 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 809 | 1.872 | 11.340 | 7.123 | 7.760 | 18.021 | 2.519 | 1.556 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Novorehab Srl